Opportunity Information: Apply for RFA CA 27 007

The NCI Community Oncology Research Program (NCORP) Community Sites funding opportunity (RFA-CA-27-007) is a National Institutes of Health (NIH), National Cancer Institute (NCI) cooperative agreement (UG1) aimed at strengthening a nationwide, community-based research network so that cancer research findings are more representative of real-world patients and can be adopted more easily in everyday care. The central idea is to expand where research happens by supporting participation and accrual in diverse community settings, not just large academic medical centers. By doing this, NCORP is intended to improve the generalizability of study results and speed up dissemination of evidence-based approaches across different health systems and patient populations.

This particular NOFO covers the “NCORP Community Sites” component of the broader NCORP program, which is one of three related NCORP funding announcements. The overall NCORP structure includes (1) NCORP Research Bases (UG1, Clinical Trials Required), (2) NCORP Community Sites (UG1, Clinical Trial Not Allowed, covered here), and (3) NCORP Academic Community Sites (UG1, Clinical Trial Not Allowed). Community Sites are positioned as the on-the-ground clinical and patient access points for NCORP and for certain National Clinical Trials Network (NCTN) studies, helping ensure studies include participants from varied geographic areas, care settings, and demographic backgrounds.

NCORP, as described in the opportunity, supports rigorous research focused on cancer control, prevention, screening, treatment and care delivery, and related human subjects studies. The program also emphasizes quality-of-life work that can be embedded within treatment trials, reflecting a broader view of cancer outcomes beyond traditional clinical endpoints. In addition, NCORP is intended to enhance access for patients and providers to treatment and imaging trials conducted under the NCTN, meaning Community Sites can serve as important bridges between national trial infrastructure and community-based oncology practices.

An NCORP Community Site, for purposes of this award, is typically a healthcare system, a consortium of healthcare systems, or a consortium of community hospitals and/or oncology practices, public hospitals, and/or other healthcare centers. The distinguishing feature is the ability to improve how representative study participants are by enrolling and engaging patients in community contexts. In practical terms, this supports research participation among patients who might otherwise be underrepresented in clinical research due to distance from academic centers, socioeconomic barriers, local care patterns, or other factors that limit trial access.

The award mechanism is a cooperative agreement (UG1), which generally indicates substantial federal scientific or programmatic involvement compared with a standard grant. While the notice headline includes “Clinical Trial Not Allowed,” the intent is that awardees under this NOFO are not funded to lead or run independent clinical trials as the primary award activity under NIH’s definition for this mechanism and solicitation. Instead, Community Sites function as network nodes that support accrual and conduct of NCORP and NCTN studies as part of the broader program framework, consistent with how NCORP is organized across Research Bases and participating sites.

Eligibility is broad across many domestic organization types, reflecting the community-based mission. Eligible applicants include various levels of government (state, county, city/township, special districts), independent school districts, public and private institutions of higher education, federally recognized tribal governments and other tribal organizations, public housing authorities/Indian housing authorities, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and other entities as specified in the NOFO. Despite this broad domestic eligibility, foreign participation is explicitly restricted: non-U.S. entities cannot apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.

From the funding metadata provided, the agency is NIH, the opportunity category is discretionary, and the activity category is health, with CFDA/assistance listings 93.393, 93.395, and 93.399. The expected number of awards is 50. The original closing date is listed as 2026-09-18. No award ceiling amount is specified in the provided source text.

Overall, this opportunity is best understood as support for community-based oncology infrastructure and participation within a national research network, with the goal of enrolling more diverse, real-world patient populations into cancer control, prevention, screening, treatment, care delivery, and quality-of-life studies. The Community Site role is to strengthen the reach and representativeness of NCI-supported research by anchoring it in community hospitals, oncology practices, and healthcare systems where most patients actually receive cancer care.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.395, 93.399.
  • This funding opportunity was created on 2026-05-21.
  • Applicants must submit their applications by 2026-09-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The number of recipients for this funding is limited to 50 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 27 007

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: NCI NCORP Community Sites (RFA-CA-27-007)

What is the NCORP Community Sites funding opportunity (RFA-CA-27-007)?

RFA-CA-27-007 is a National Institutes of Health (NIH), National Cancer Institute (NCI) cooperative agreement (UG1) that supports the NCI Community Oncology Research Program (NCORP) Community Sites. The purpose is to strengthen a nationwide, community-based oncology research network so cancer research findings better reflect real-world patients and can be adopted more easily in everyday care.

What is the main goal of NCORP Community Sites?

The core goal is to expand where research happens by supporting participation and accrual in diverse community settings (not only large academic medical centers). This is meant to improve how representative study participants are, increase the generalizability of results, and speed dissemination of evidence-based approaches across different health systems and patient populations.

How do NCORP Community Sites fit within the broader NCORP program?

This NOFO covers the “NCORP Community Sites” component, which is one of three related NCORP funding announcements. The overall NCORP structure includes: (1) NCORP Research Bases (UG1, Clinical Trials Required), (2) NCORP Community Sites (UG1, Clinical Trial Not Allowed - this opportunity), and (3) NCORP Academic Community Sites (UG1, Clinical Trial Not Allowed).

What types of organizations are considered an NCORP Community Site under this award?

An NCORP Community Site is typically a healthcare system, a consortium of healthcare systems, or a consortium of community hospitals and/or oncology practices, public hospitals, and/or other healthcare centers. The distinguishing feature is the ability to enroll and engage patients in community contexts to improve the representativeness of research participants.

What kinds of research areas does NCORP support?

NCORP supports rigorous research focused on cancer control, prevention, screening, treatment, and care delivery, as well as related human subjects studies. It also emphasizes quality-of-life work that can be embedded within treatment trials, reflecting outcomes beyond traditional clinical endpoints.

How does this opportunity help make research more representative of real-world patients?

By anchoring research participation in community hospitals, oncology practices, and healthcare systems where most patients receive care, NCORP Community Sites help enroll participants from varied geographic areas, care settings, and demographic backgrounds. This can reduce underrepresentation driven by distance from academic centers, socioeconomic barriers, local care patterns, and other access limitations.

What does it mean that this is a cooperative agreement (UG1)?

A UG1 cooperative agreement generally indicates substantial federal scientific or programmatic involvement compared with a standard grant. This reflects a networked, program-coordinated approach where sites contribute within the broader NCORP framework.

The NOFO says “Clinical Trial Not Allowed.” What does that mean for Community Sites?

Under this NOFO, awardees are not funded to lead or run independent clinical trials as the primary award activity under NIH’s definition for this mechanism and solicitation. Instead, Community Sites function as network nodes that support accrual and conduct of NCORP and certain National Clinical Trials Network (NCTN) studies as part of the broader program structure.

Can NCORP Community Sites participate in NCTN studies?

Yes. NCORP is intended to enhance access for patients and providers to treatment and imaging trials conducted under the NCTN, and Community Sites can serve as bridges between national trial infrastructure and community-based oncology practices.

Who is the funding agency for this opportunity?

The agency is the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI).

What is the opportunity category and activity category?

The opportunity category is discretionary, and the activity category is health.

What types of applicants are eligible to apply?

Eligibility is broad across many domestic organization types, including: various levels of government (state, county, city/township, special districts), independent school districts, public and private institutions of higher education, federally recognized tribal governments and other tribal organizations, public housing authorities/Indian housing authorities, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and other entities as specified in the NOFO.

Are foreign organizations eligible to apply?

No. Foreign participation is explicitly restricted. Non-U.S. entities cannot apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.

What is the expected number of awards?

The expected number of awards is 50.

What is the application closing date listed in the provided information?

The original closing date is listed as 2026-09-18.

Is there an award ceiling (maximum funding amount) specified?

No award ceiling amount is specified in the provided source text.

What are the CFDA/assistance listings associated with this opportunity?

The CFDA/assistance listings are 93.393, 93.395, and 93.399.

What practical role do Community Sites play in the NCORP network?

Community Sites are positioned as on-the-ground clinical and patient access points for NCORP (and for certain NCTN studies). They help ensure studies include participants from varied geographic areas, care settings, and demographic backgrounds, strengthening the reach and representativeness of NCI-supported research.

Why does NCI emphasize community settings instead of only academic medical centers?

The program is designed to support participation and accrual in diverse community settings so study results are more generalizable to real-world patients and the resulting evidence-based approaches can be adopted more easily across everyday care environments.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Acer Access and Development Program

Previous opportunity: DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator Award

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 27 007

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 27 007) also looked into and applied for these:

Funding Opportunity
NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required) Apply for RFA CA 27 006

Funding Number: RFA CA 27 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) Apply for PAR 27 026

Funding Number: PAR 27 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed) Apply for RFA CA 27 008

Funding Number: RFA CA 27 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36 - Clinical Trial Not Allowed) Apply for RFA OD 27 006

Funding Number: RFA OD 27 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) Apply for RFA OD 27 008

Funding Number: RFA OD 27 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) Apply for RFA MH 27 140

Funding Number: RFA MH 27 140
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) Apply for RFA NS 27 007

Funding Number: RFA NS 27 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single Source: Cardiothoracic Surgical Trials Network (CTSN) Data Coordinating Center (U01 Clinical Trial Required) Apply for RFA HL 27 002

Funding Number: RFA HL 27 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $8,000,000
Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional) Apply for RFA MH 27 180

Funding Number: RFA MH 27 180
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed) Apply for RFA RM 27 014

Funding Number: RFA RM 27 014
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed) Apply for RFA RM 27 015

Funding Number: RFA RM 27 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $575,000
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional) Apply for RFA RM 27 012

Funding Number: RFA RM 27 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed) Apply for RFA HG 27 011

Funding Number: RFA HG 27 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,250,000
Limited Competition for the Adolescent Brain Cognitive Development -Extended (ABCD-E) Study Renewal - Data Analysis, Informatics and Resource Center, and Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA DA 27 003

Funding Number: RFA DA 27 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
GREGoRi Technology Integration Center (U01, Clinical Trials Optional) Apply for RFA HG 27 012

Funding Number: RFA HG 27 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,250,000
GREGoRi Innovation Projects (U01 Clinical Trial Optional) Apply for RFA HG 27 013

Funding Number: RFA HG 27 013
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Renewal of the Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AG 27 007

Funding Number: RFA AG 27 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) Apply for RFA ES 27 004

Funding Number: RFA ES 27 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,750,000
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) Apply for PAR 27 098

Funding Number: PAR 27 098
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) Apply for PA 27 100

Funding Number: PA 27 100
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 27 007", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: